847906-27-8 Usage
Uses
Used in Pharmaceutical Industry:
3-Iodo-7-Methyl (1H)Indazole is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique chemical structure allows for the development of new compounds with potential therapeutic applications.
Used in Chemical Research:
3-Iodo-7-Methyl (1H)Indazole is used as a research compound in the field of organic chemistry. Its properties and reactivity can be studied to gain insights into the behavior of similar compounds and to develop new synthetic methods.
Used in Material Science:
3-Iodo-7-Methyl (1H)Indazole is used as a component in the development of new materials. Its unique structure may contribute to the creation of materials with specific properties, such as improved stability or enhanced reactivity.
Note: The uses listed above are hypothetical and based on the general properties of 3-Iodo-7-Methyl (1H)Indazole. The actual applications may vary depending on the specific context in which the compound is being used. As with any chemical, appropriate safety measures should be taken when handling 3-Iodo-7-Methyl (1H)Indazole.
Check Digit Verification of cas no
The CAS Registry Mumber 847906-27-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,7,9,0 and 6 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 847906-27:
(8*8)+(7*4)+(6*7)+(5*9)+(4*0)+(3*6)+(2*2)+(1*7)=208
208 % 10 = 8
So 847906-27-8 is a valid CAS Registry Number.
InChI:InChI=1/C8H7IN2/c1-5-3-2-4-6-7(5)10-11-8(6)9/h2-4H,1H3,(H,10,11)
847906-27-8Relevant articles and documents
SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF
-
Paragraph 01237, (2018/08/03)
Provided herein are small molecule activators of Nicotinamide Phosphoribosyltransferase (NAMPT), compositions comprising the compounds, and methods of using the compounds and compositions.
Gyrase inhibitors
-
Page/Page column 73, (2008/06/13)
Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
